2019
DOI: 10.4274/balkanmedj.galenos.2019.2019.10.23
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Embolization Technique for Renal Hemorrhage Complication by Autologous Fat Tissue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…This new molecule, called LGIOC (Lithium-gamma-linolenic acid conjugated to an oily lymphographic agent), when injected close to the tumor feeding vessel completely blocked all the tumor feeding vessels without any effect on normal blood vessels (Figures 2, 3). In this instance, the gamma-linolenic acid used is also a lipid (fat) but is different from the subcutaneous fat used by Ari et al (2). It is possible that the subcutaneous fat used by Ari et al (2) also contains some amount of gamma-linolenic acid, but this needs to be confirmed by further analysis.…”
Section: Vaso-occlusive Action Of Lipidsmentioning
confidence: 80%
See 3 more Smart Citations
“…This new molecule, called LGIOC (Lithium-gamma-linolenic acid conjugated to an oily lymphographic agent), when injected close to the tumor feeding vessel completely blocked all the tumor feeding vessels without any effect on normal blood vessels (Figures 2, 3). In this instance, the gamma-linolenic acid used is also a lipid (fat) but is different from the subcutaneous fat used by Ari et al (2). It is possible that the subcutaneous fat used by Ari et al (2) also contains some amount of gamma-linolenic acid, but this needs to be confirmed by further analysis.…”
Section: Vaso-occlusive Action Of Lipidsmentioning
confidence: 80%
“…Of more than 170 transcripts expressed in the endothelium, 70 were differentially expressed, including 46 that were specifically increased in tumor-associated endothelium (7), suggesting that there are significant differences in gene expression profiles in endothelium derived from normal and tumor vessels. It is possible that LGIOC [and possibly, the subcutaneous fat tissue used by Ari et al (2)] can stimulate some of the genes and/or receptors in the endothelium of the tumor blood vessels, which may have a role in the occlusion of the tumor vessels observed in our study. Thus, there is seems to be a significant role for subcutaneous fat and LGIOC and similar lipids in specifically occluding abnormal vessels (tumor feeding vessels, arterio-venous malformations, or vessels that rupture and bleed during some procedures).…”
Section: Vaso-occlusive Action Of Lipidsmentioning
confidence: 83%
See 2 more Smart Citations
“…Recently, Arı et al . [ 13 ] used subcutaneous fat embolization for treating a renal artery perforation during percutaneous nephrolithotomy. In contrast with these reports, we used this method not for treating a complication but the situation itself.…”
Section: Discussionmentioning
confidence: 99%